Cargando…
Development and Validation of a Five-RNA–Based Signature and Identification of Candidate Drugs for Neuroblastoma
Neuroblastoma (NBL) originating from the sympathetic nervous system is the most prevalent solid tumor in infancy. Although there is sufficient variability in prognosis among different age pyramids, age-related gene expression profiles and biomarkers remain poorly explored. The present study aimed to...
Autores principales: | Zhang, PeiPei, Ma, KeXin, Ke, XiaoFei, Liu, Liu, Li, Ying, Liu, YaJuan, Wang, YouJun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564070/ https://www.ncbi.nlm.nih.gov/pubmed/34745201 http://dx.doi.org/10.3389/fgene.2021.685646 |
Ejemplares similares
-
A signature based on five immune-related genes to predict the survival and immune characteristics of neuroblastoma
por: Ma, KeXin, et al.
Publicado: (2022) -
Identification and Validation of a Five-Gene Diagnostic Signature for Preeclampsia
por: Liu, Yu, et al.
Publicado: (2022) -
Identification and validation of neurotrophic factor-related genes signature in HNSCC to predict survival and immune landscapes
por: Peng, Gaoge, et al.
Publicado: (2022) -
Identification of Potential Prognostic Genes for Neuroblastoma
por: Zhong, Xiaodan, et al.
Publicado: (2018) -
Identification and Validation of an Immunological Expression-Based Prognostic Signature in Breast Cancer
por: Pei, Jianying, et al.
Publicado: (2020)